Europol–EMCDDA Joint Report on a new psychoactive substance: 1-(3-chlorophenyl)piperazine (mCPP)

DSpace Repository

Show simple item record

dc.contributor Europol
dc.contributor European Monitoring Centre for Drugs and Drug Addiction
dc.date.accessioned 2019-04-03T09:03:15Z
dc.date.available 2019-04-03T09:03:15Z
dc.date.issued 2005
dc.identifier.other 1699777195 de_DE
dc.identifier.uri http://hdl.handle.net/10900/87508
dc.identifier.uri http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-875088 de_DE
dc.identifier.uri http://dx.doi.org/10.15496/publikation-28894
dc.description.abstract In August 2005, after examining the available information collected on mCPP (1-(3-chlorophenyl)piperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint report. The report concluded that mCPP seemed unlikely to establish itself as a recreational drug in its own right and recommended that, in view of the fact that the substance was used in the manufacture of at least one medicinal product, no risk assessment should be carried out. Following the recommendations of the report, in 2006 the Commission requested an active monitoring of the substance. The Active monitoring report presents further data on mCPP and the risks it poses. en
dc.language.iso en de_DE
dc.publisher Universität Tübingen de_DE
dc.subject.classification Drogenmissbrauch , Drogenkonsum de_DE
dc.subject.ddc 360 de_DE
dc.title Europol–EMCDDA Joint Report on a new psychoactive substance: 1-(3-chlorophenyl)piperazine (mCPP) en
dc.type Report (Bericht) de_DE
utue.publikation.fachbereich Kriminologie de_DE
utue.publikation.fakultaet Kriminologisches Repository de_DE
utue.opus.portal kdoku de_DE

Dateien:

This item appears in the following Collection(s)

Show simple item record